|
Characteristics
|
Study cohort n = 471
|
|---|
|
Total
|
(% missing)
|
Cases ( n)
|
(%)
|
|---|
|
General characteristics
| | | | |
|
Male gender a
|
471
|
(0)
|
260
|
55.2%
|
|
Outcome measure
| | | | |
|
Hearing loss a
|
471
|
(0)
|
34
|
7.2%
|
|
Clinical predictors
| | | | |
|
Duration of symptoms > 2 daysa
|
464
|
(1.5)
|
110
|
23.7%
|
|
Petechiae a
|
463
|
(1.7)
|
273
|
59.0%
|
|
CSF glucose ≤ 0.6 mmol/l a
|
418
|
(11.2)
|
125
|
29.9%
|
|
Causative pathogen in CSF:
|
471
|
(0)
| | |
|
N. meningitidis
a
| | |
391
|
83%
|
|
S. pneumoniae
a
| | |
80
|
17%
|
|
(transient) ataxia a. b
|
471
|
(0)
|
16
|
3.4%
|
-
a Number of subjects (%).
-
b (Transient) ataxia was defined as signs of ataxia, which lasted at least until discharge from the hospital, as documented in the medical records.
- Abbreviations:
-
No.: Number.
-
CSF: Cerebrospinal fluid.
